Latest CHOP Stories
Lymphoma is often difficult to treat in elderly patients because they cannot always tolerate chemotherapy.
SEATTLE, April 4, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
SEATTLE, March 21, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has initiated its randomized pivotal trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma ("DLBCL").
ORLANDO, Fla., Dec. 5, 2010 /PRNewswire-USNewswire/ -- The next generation of drug therapies and enhanced treatment approaches for various forms of lymphoma are evolving as researchers continue to better understand how these cancers progress.
SEATTLE, May 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA) reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen.
Good Shepherd To Manage Medical Rehabilitation Services for CHOP ALLENTOWN, Pa., May 13 /PRNewswire-USNewswire/ -- Good Shepherd Rehabilitation Network (GSRN) based in Allentown, Pennsylvania, and the Children's Hospital of Philadelphia (CHOP) have signed a management contract whereby GSRN will manage all medical rehabilitation services provided to CHOP's patients.
There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in order to discover new treatment options and provide patients with the best care.
NEW ORLEANS, Dec.
SEATTLE, Oct. 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that Dr.
Updated Safety data presented at BIO International Convention in Atlanta ATLANTA, May 19 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.